Recital 9, Regulation (EU) 2020/484

In forcesince 2 Apr 2020

Following the receipt of the Authority’s scientific opinion, the Commission requested the applicant to further clarify the justification provided with regard to their the proprietary analytical reports on the structure comparison via NMR of LNT produced by bacterial fermentation with LNT naturally present in human milk, the report on the detailed characterisation data on the production bacterial strains and their certificates, the report on the specifications for the raw materials and processing aids, the certificates of analyses of the various LNT batches, the analytical methods and validation reports, the LNT stability reports, the detailed description of the production process, the laboratory accreditation certificates, the in vitro mammalian cell micronucleus test with LNT and its summary table of the statistically significant observations, a second in vitro mammalian cell micronucleus test with LNT and its summary table of the statistically significant observations, a bacterial reverse mutation test with LNT, a 14-day oral toxicity study in the neonatal rat with LNT, and a 90-day oral toxicity study in the neonatal rat with LNT and its summary table of the statistically significant observations as referred to in point (b) of Article 26(2) of Regulation (EU) 2015/2283.